American Marconi Wireless News

NYSE - LSE

CMSC	0.4%	22.314	$
CMSD	0.11%	22.285	$
RBGPF	0%	69.04	$
SCS	0.37%	10.74	$
RELX	0.06%	53	$
RIO	-0.24%	59.33	$
GSK	0.31%	41.45	$
NGG	0.38%	71.48	$
BP	0.58%	30.4	$
BTI	1.48%	48.215	$
BCC	0.87%	91.02	$
JRI	0.15%	13.13	$
VOD	0.1%	9.85	$
BCE	-0.27%	22.445	$
RYCEF	0.83%	12	$
AZN	-0.16%	73.71	$

Featured

At least 10 dead in Colombia landslide

A landslide triggered by heavy rains killed at least 10 people and injured eight others Tuesday near the Colombian city of Medellin, government officials said.

US judge backs using copyrighted books to train AI

A US federal judge has sided with Anthropic regarding training its artificial intelligence models on copyrighted books without authors' permission, a decision with the potential to set a major legal precedent in AI deployment.

Last news

Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results

Net income of $4.0 million, or $0.65 and $0.21 net income per share basic and diluted, respectively

CV Sciences, Inc. Reports First Quarter 2025 Financial Results

SAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2025.

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025

HILLSIDE, NJ / ACCESS Newswire / May 14, 2025 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2025.

Greer Consulting Inks 12-Month Media Deal with New to The Street to Launch National Campaign

"Workplace Power with Jason Greer" to Begin Filming This Month, Featuring Long-Form Interviews, Earned Media, and Iconic Outdoor Billboards

Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3

STONY BROOK, NY / ACCESS Newswire / May 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, will release its financial results for the second quarter of fiscal year 2025 (ended on March 31, 2025) after the close of the U.S. equity markets on Thursday, May 15, 2025. The Company's Form 10-Q for the period will be filed concurrently and available on the SEC Filings page of its Investor Relations website.

Licensing Expo Partners with Qwoted to Power Press Lounge Experience at 2025 Show

LAS VEGAS, NV / ACCESS Newswire / May 14, 2025 / Licensing Expo, the world's largest and most influential annual licensing trade show, announces Qwoted as the official Press Lounge sponsor for its upcoming show at Mandalay Bay Convention Center, May 20-22, 2025. Licensing Expo serves as the cornerstone gathering for decision-makers in consumer branded merchandise.

MEMRI Congratulates Board Of Advisors Member Brig. Gen. Tom Consentino On New Role

WASHINGTON, DC / ACCESS Newswire / May 14, 2025 / The Middle East Media Research Institute (MEMRI) congratulates our Board of Advisors member Brig. Gen. Tom Cosentino on his new role as CEO of Governance Risk Global Holdings (GRG).

Desert Oasis Healthcare Leads the Way in Dementia Detection with Cutting-Edge Digital Screening Tool

Neurotrack's screening platform helped to increase the rate of dementia detection by 29% in four months

Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

- Dermata announced positive topline results from its XYNGARI™ Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial, achieving all co-primary endpoints -- Dermata entered into a Clinical Trial Collaboration Agreement with Revance Therapeutics to study DMT410 with DAXXIFY® for the treatment of axillary hyperhidrosis -- Raised $8.8 million in gross proceeds from private placement and warrant inducement financings during the first quarter of 2025 -

Cognixion and Blackrock Neurotech Expand Access to Non-Invasive, Multi-Modal BCI Research with Axon-R

Blackrock Neurotech to begin immediate sales of Cognixion's Axon-R wearable BCI + augmented reality platform, paving the way for integration of implantable BCI with immersive computing applications

Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates

Click here to registerCompany plans to file its Earnings Report on May 15, 2025 on Form 10-Q for the quarter ended March 31, 2025

Interactive Strength Inc. (Nasdaq:TRNR) To Release First Quarter 2025 Results on Monday, May 19th

Company also expects to provide Q1 performance update pro forma for the pending acquisitions of Sportstech and Wattbike

Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors

412% revenue growth reflects AI Nose sales in elderly careExpanding AI-driven scent tech beyond healthcare into robotics and industrial applications

Reservoir Media to Release Fourth Quarter and Fiscal Year 2025 Results on May 28, 2025

NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Reservoir Media, Inc. (NASDAQ:RSVR) ("Reservoir" or the "Company"), an award-winning independent music company, today announced that it will release financial results for the fourth fiscal quarter and fiscal year 2025 ended March 31, 2025, before market open on Wednesday, May 28, 2025.

Specificity Builds Dominant CTV Campaign Capabilities, Reinforces Position as Industry's Leading Hybrid Marketing Agency

TAMPA, FLORIDA / ACCESS Newswire / May 14, 2025 / Specificity, Inc. (OTC PINK:SPTY), the marketing industry's only true hybrid model agency, today announced the expansion of its cutting-edge Connected TV (CTV) advertising capabilities, delivering unmatched performance, precision, and value for clients looking to reach real, in-market audiences.

Measles Cases Are Increasing Globally; MPox Continues to Be a Threat - Broad-Spectrum Antiviral Drug Could Be the Solution

NanoViricides Explains Its Drug Strategy for Combating Viral Infections and Pandemics

Fenjiu Liquor Elegance, Shared Worldwide: Asia-Pacific Cuisine Sino-Singapore Forum Successfully Concludes in Auckland

Fenjiu Shines at Asia-Pacific Culinary Forum: China-New Zealand Fusion Captivates Auckland

Coca-Cola Europacific Partners plc Announces Capital Markets Event

UXBRIDGE, UNITED KINGDOM / ACCESS Newswire / May 14, 2025 / CCEP today hosts a Capital Markets Event in Manila for analysts and investors.

Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol

Amendment to Clinical Protocol for HG-CT-1 to Include Pediatric Patients with R/R AML

UN agency finds Russia responsible for 2014 downing of airliner over Ukraine

The United Nations aviation agency has blamed Russia for the downing of a Malaysian jetliner over Ukraine in 2014, leading to the deaths of 298 people, a ruling dismissed by Moscow on Tuesday as "biased."

'I thought I was going to die,' Kardashian tells Paris robbery trial

Reality TV star Kim Kardashian told a Paris court on Tuesday she feared she would be killed by the masked men who robbed her at gunpoint of some $10 million of jewellery in her hotel room in 2016.

Sean 'Diddy' Combs' ex Cassie expected to testify

Sean "Diddy" Combs's former partner Casandra Ventura is expected to testify at his trial Tuesday with a now infamous clip of the fallen music mogul allegedly beating the singer expected to dominate questioning.

French court convicts Depardieu of sexual assault

A Paris court on Tuesday handed French cinema icon Gerard Depardieu an 18-month suspended sentence after convicting him of sexually assaulting two women on a film set in 2021.

Medical charity condemns Israel's use of hunger as 'weapon of war' in Gaza

A months-long Israeli blockade is worsening acute malnutrition in the Gaza Strip, medical charity Medecins du Monde warned on Tuesday, accusing Israel of using hunger as "a weapon of war".

Gerard Depardieu: a tarnished French film icon

Gerard Depardieu was a titan of French cinema for more than 50 years but a sexual assault conviction, a string of other allegations and several instances of lewd behaviour now cast a long, dark shadow over what was once a glittering career.

Tariffs set to level up game console prices

The US tariffs barrage and the bounding cost of producing games have prompted manufacturers like Sony and Microsoft to announce price hikes on consoles, in an industry shift experts say is set to last.

Jaded young Chinese reset lives with rural 'retirement'

Wang Dong hasn't worked for months and doesn't plan to, whiling away his days at a lakeside town as one of a growing number of young Chinese "retiring" in the countryside.

Verdict due in Depardieu sexual assault case

A Paris court is to deliver a verdict Tuesday in the sexual assault trial of French cinema icon Gerard Depardieu, in a case that has further tarnished the reputation of one of France's greatest stars.

'Unlimited power': Testimony against Sean Combs tells of lurid violence

The courtroom fell eerily silent as the footage of Sean "Diddy" Combs beating, kicking and dragging his then-girlfriend began -- a video already seen worldwide but which took on new gravity played before the jurors who will determine his future.

Angel Media Unveils Iconic New Hand-Painted Billboard in NYC’s Meatpacking District

This premium wallscape is more than just advertising - it's cultural placement. The Meatpacking District is a global destination known for its fashion-forward crowd, luxury retail, buzzing nightlife, and creative energy. This location puts brands front and center in a high-foot-traffic corridor surrounded by art galleries, tech headquarters, and trendsetting locals and tourists alike.

NHI Responds to ISS Recommendation

Urges Shareholders to Vote FOR NHI's Director Nominees on the WHITE Proxy CardStrongly Disagrees with ISS' Recommendation; Believes that it Would Put at Risk Company's Superior Shareholder Returns

Ensysce Biosciences Reports First Quarter 2025 Financial Results

Receives U.S. Patent for Groundbreaking Treatment for Opioid Use DisorderClinical Trial on Novel Analgesic, PF614-MPAR, Demonstrates Overdose Protection

American Marconi Wireless News - Boulevard (English)